Cynthialy CEO to speak on AI implementation strategy at summer conference

Cynthialy, a Tokyo-based AI consulting and development company established in October 2022, announced that CEO Tomori Kunimoto will take part in a panel discussion at the AI BUSINESS CONFERENCE 2026 Summer, scheduled to run online from July 15–17, 2026.

Kunimoto's session, titled "Learning from Chugai Pharmaceutical: The Essence of AI × Transformation—Overcoming the PoC Valley with MVP Strategy," is set for Friday, July 17, 2026, from 10:00–10:50 a.m. The format is a conversation between Kunimoto and Takao Suzuki, a senior executive (Sanyo) at Chugai Pharmaceutical who leads the company's Digital Transformation Unit. According to the session description, the discussion will address how organizations become stuck in a pattern where proof-of-concept projects fail to deliver results, and will explore concrete strategies for accelerating business transformation through MVP strategy and organizational AI implementation centered on a center-of-excellence model.

The broader AI BUSINESS CONFERENCE 2026 Summer is a free, fully online event organized by SmartCamp Inc. It is designed for business leaders interested in AI adoption and the value creation that can follow. The conference combines structured talks that map a path from operational efficiency gains to organizational transformation with exposure to current trends and real-world case studies.

Cynthialy describes itself as an "AI Work Transformation Company" that supports enterprises through a range of services: generative AI-driven employee training and retention consulting, development of AI agents and AI virtual humans, and hands-on implementation of cutting-edge AI tools such as Microsoft Copilot and Google Gemini. The company works primarily with large enterprises and holds deep expertise in real-world AI deployment in professional settings.

Cynthialy's participation in this conference reflects a broader industry focus on the gap between AI experimentation and actual operational deployment. While many large organizations in Japan have launched proof-of-concept projects with generative AI, translating those pilots into sustained business value and organizational change has proven difficult. The panel featuring both Cynthialy and Chugai Pharmaceutical—a major pharmaceutical company actively pursuing digital transformation—signals industry recognition that success requires not just technology selection but also organizational strategy, change management, and what the event frames as a center-of-excellence (CoE) approach to AI implementation.

The timing of this announcement (for an event in summer 2026) reflects the maturation phase of AI adoption in Japanese enterprise. Companies are moving beyond initial curiosity about generative AI toward questions of scaling, sustainability, and measurable business impact. Cynthialy's emphasis on "MVP strategy" (minimum viable product strategy) and organizational embedding suggests the firm positions itself as a bridge between AI vendors and the internal organizational work required to make AI change stick—a consultative rather than purely technical offering.

No comments yet. Be the first to share your thoughts!